Skip to main content
Clinical Trials/EUCTR2010-020724-21-AT
EUCTR2010-020724-21-AT
Active, not recruiting
Phase 1

Amyloid Imaging with [11C]PIB PET and MRI in MCI – a pilot study - MCI and PIB

niversitätsklinik für Neurologie, Medizinische Universität Wien0 sitesFebruary 10, 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitätsklinik für Neurologie, Medizinische Universität Wien
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 10, 2011
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversitätsklinik für Neurologie, Medizinische Universität Wien

Eligibility Criteria

Inclusion Criteria

  • Age range between 60\-80 years, male and female
  • Neuropsychological Testing with diagnosis of Mild Cognitive impairment – amnestic or non amnestic type (single and multiple domain).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • major life threatening internal diseases, for example heart failure, cancer, ..
  • major neurological diseases except MCI, for example major stroke, parkinsonism
  • major psychiatric diseases except dementia, for example major depression

Outcomes

Primary Outcomes

Not specified

Similar Trials